Cardiology Neuro Oncology Structural Heart

Amid Q4 letdown, Boston Scientific aims for $1B mark in structural heart

Released on January 15, 2020

After reporting a fourth-quarter revenue shortfall due to a slowdown in its cardiac rhythm management division, Boston Scientific on Tuesday said […]

Read more
Cardiology FDA Approved Structural Heart

Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients

Released on January 13, 2020

ABBOTT PARK, Ill., Jan. 13, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved a first-of-its-kind […]

Read more
Cardiology Structural Heart

JenaValve TAVR wins FDA breakthrough device designation

Released on January 10, 2020

JenaValve Technology said today that FDA has granted breakthrough device designation for its JenaValve Pericardial TAVR. The designation is for severe aortic […]

Read more
Cardiology MedTech Structural Heart

Miles White’s fearless strategy for growing Abbott

Released on January 10, 2020

With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into […]

Read more
FDA Structural Heart

Does JenaValve’s New Designation Signal the Start of Another Strong Year for TAVR?

Released on January 9, 2020

JenaValve is showing significant progress in the plan to get its transcatheter aortic valve replacement (TAVR) system approved. FDA granted the […]

Read more
Cardiology Funding Structural Heart

Neovasc closes $10m direct offering

Released on January 8, 2020

Neovasc (NSDQ:NVCN) announced that has it closed its previously announced registered direct offering for aggregate gross proceeds reaching approximately $10 million. The […]

Read more
Cardiology FDA Approved Structural Heart

Abbott LVAD wins FDA approval for implantation without open heart surgery

Released on January 7, 2020

Abbott (NYSE:ABT) today announced that FDA has approved implantation of its HeartMate 3 LVAD via lateral thoracotomy — a less invasive approach […]

Read more
Cardiology FDA Structural Heart

Abbott’s New Designation Helps Advance its Position in LVAD Market

Released on January 7, 2020

Abbott Laboratories has won a nod from FDA for a new alternative surgical technique for the HeartMate 3 Left Ventricular Assist […]

Read more
Cardiology Structural Heart

Abbott warns of issues with HeartMate 3 cable, mobile power unit

Released on December 10, 2019

Dive Brief: Abbott is warning doctors of the potential for harm to patients from two separate issues involving equipment used to […]

Read more
Cardiology Structural Heart

Company of the Year: Edwards Lifesciences

Released on December 9, 2019

Edwards Lifesciences changed the way heart valve disease is treated in 2019. It was not the first time the medtech turned […]

Read more
Cardiology Structural Heart

InnovHeart Appoints Brent Ratz as Independent member of the board

Released on December 6, 2019

MILAN, Dec. 5, 2019 /PRNewswire/ — InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with […]

Read more
Cardiology Structural Heart

Analysts cool expectations for Edwards’ mitral performance

Released on December 6, 2019

Dive Brief: Edwards Lifesciences intends to match the high it set this year for R&D spending again in 2020, supporting 10 pre- […]

Read more